Filippo Montemurro
Roche (Switzerland)(CH)Candiolo Cancer Institute(IT)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Estrogen and related hormone effects
Most-Cited Works
- → Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer(2021)702 cited
- → Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer(2007)624 cited
- → Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆(2020)333 cited
- → Correlations between diffusion-weighted imaging and breast cancer biomarkers(2012)243 cited
- → Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging(2004)241 cited
- → Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial